BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 34299246)

  • 21. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner.
    Liu Z; Hu C; Zheng L; Liu J; Li K; Li X; Wang Y; Mu W; Chen T; Shi A; Qiu B; Zhang X; Zhang Z; Xu Y
    Cell Mol Life Sci; 2022 Aug; 79(9):469. PubMed ID: 35932322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.
    Sun R; Liu Z; Qiu B; Chen T; Li Z; Zhang X; Xu Y; Zhang Z
    EBioMedicine; 2019 Sep; 47():142-155. PubMed ID: 31492557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells.
    Li W; Sun Z; Chen C; Wang L; Geng Z; Tao J
    Biomed Pharmacother; 2018 Apr; 100():257-266. PubMed ID: 29438839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
    Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-373 inhibits autophagy and further promotes apoptosis of cholangiocarcinoma cells by targeting ULK1.
    Lv P; Luo YF; Zhou WY; Liu B; Zhou Z; Shi YZ; Huang R; Peng C; He ZL; Wang J; Zhang HH; Nie SD
    Kaohsiung J Med Sci; 2020 Jun; 36(6):429-440. PubMed ID: 32125086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
    Chang W; Wang Y; Li W; Geng Z
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.
    Utaijaratrasmi P; Vaeteewoottacharn K; Tsunematsu T; Jamjantra P; Wongkham S; Pairojkul C; Khuntikeo N; Ishimaru N; Sirivatanauksorn Y; Pongpaibul A; Thuwajit P; Thuwajit C; Kudo Y
    Mol Cancer; 2018 Jan; 17(1):10. PubMed ID: 29347950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOX4 is associated with poor prognosis in cholangiocarcinoma.
    Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
    Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of KCNQ1OT1 promotes cholangiocarcinoma progression via miR-140-5p/SOX4 axis.
    Sun H; Li Y; Kong H; Dai S; Qian H
    Arch Biochem Biophys; 2018 Nov; 658():7-15. PubMed ID: 30243712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer.
    Liu P; Zhang C; Liao Y; Liu J; Huang J; Xia M; Chen M; Tan H; He W; Xu M; Liu T; Ooi S; Du Q; Qin S; Zhu Y; Zou Q; Wang W; Yao S
    Cell Death Dis; 2020 Aug; 11(8):687. PubMed ID: 32826853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
    Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular RNAs in cholangiocarcinoma.
    Liao W; Feng Q; Liu H; Du J; Chen X; Zeng Y
    Cancer Lett; 2023 Jan; 553():215980. PubMed ID: 36336149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
    Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients.
    Chen T; Wang H; Yan H
    Cell Cycle; 2022 Oct; 21(19):2079-2090. PubMed ID: 35670491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
    Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q
    Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
    Yang J; Sontag D; Gong Y; Minuk GY
    Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA-seq Data and
    Yao Y; Jiao D; Liu Z; Chen J; Zhou X; Li Z; Li J; Han X
    Biomed Res Int; 2020; 2020():5976127. PubMed ID: 33490245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of noncoding RNAs in cholangiocarcinoma (Review).
    Lv Y; Wang Z; Zhao K; Zhang G; Huang S; Zhao Y
    Int J Oncol; 2020 Jul; 57(1):7-20. PubMed ID: 32319584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.